Browse all Canadian datasets
Browse the complete CanQuery catalogue, including downloadable files, live tables and maps.
Open datasets
- Amendments to the Food and Drug Regulations - Nutrition Labelling
- Amendments to the Food and Drug Regulations - Division 15 and 16 Clean Up for Food Additives
- Amendments to the Food and Drug Regulations Restricting the Marketing of Unhealthy Foods to Children
- Regulating food
- Government of Canada COVID-19 Situational Awareness Dashboard
- 2020-09-21 Decisions Décisions
- Water Bodies
- 2020-09-21 Recommendations Recommandations
- 2020-09-21 Agenda Ordre du jour
- Bylaw No. 7748 Subdivision Bylaw
- Patent Act Schedules related to Canada's Access to Medicines Regime
- Benefits for companies participating in Canada's Access to Medicines Regime
- Introduction to the Canada's Access to Medicines Regime
- Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences
- Guidance document on Public Release of Clinical Information: profile page
- WTO-member countries eligible to import under Canada's Access to Medicines Regime
- Compulsory licences under Canada's Access to Medicines Regime
- Country access to Canada's Access to Medicines Regime
- Public Release of Clinical Information: consultation
- Guidance Document: Administrative Processing of Submissions and Applications Involving Human or Disinfectant Drugs
- Improving the regulatory review of drugs and devices: Drugs - Special Access to Drugs and Health Products
- Improving the regulatory review of drugs and devices: Improving access to generic drugs
- Improving the regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needs
- Improving the regulatory review of drugs and devices: Early scientific advice to manufacturers
- Improving the regulatory review of drugs and devices: Notice to industry - Aligned reviews between Health Canada and health technology assessment organizations
- Regulatory Initiative: Amendments to the Food and Drug Regulations - Mandatory Reporting of Drug Shortages - Forward Regulatory Plan 2015-2017
- Features of Canada's Access to Medicines Regime
- WTO-member countries and non-WTO member countries eligible to import under Canada's Access to Medicines Regime
- Least-developed countries eligible to import under Canada's Access to Medicines Regime
- Capacity to manufacture under Canada's Access to Medicines Regime
- Anti-diversionary measures under Canada's Access to Medicines Regime
- Role of Non-Governmental Organizations in Canada's Access to Medicines Regime
- How to comply with procedures under Canada's Access to Medicines Regime
- Termination of authorization under Canada's Access to Medicines Regime
- Good faith clause under Canada's Access to Medicines Regime
- Renewal of licence under Canada's Access to Medicines Regime
- Declaring monetary value and units sold under Canada's Access to Medicines Regime
- Declaring an attempt at negotiating a voluntary licence under Canada's Access to Medicines Regime
- Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines Regime
- Submit an application under Canada's Access to Medicines Regime
- Royalty payments and Canada's Access to Medicines Regime
- Process map of terms and conditions of a compulsory licence under Canada's Access to Medicines Regime
- Process map for preparing to submit an application under Canada's Access to Medicines Regime
- Company requirements under Canada's Access to Medicines Regime
- Canada's Access to Medicines Regime documents
- Canada's Access to Medicines Regime background
- Guidance on Medical Device Compliance and Enforcement (GUI-0073)
- Guidance on Medical Device Establishment Licensing (GUI-0016)
- Canada's Access to Medicines Regime
- Safe Medical Devices in Canada